The survival rate for breast cancer drops dramatically once the disease progresses to the metastatic stage. Selenium (Se) is an essential micronutrient credited with having high anticancer and chemopreventive properties. In our study, we investigated if dietary Se supplementation modified breast cancer development in vivo. Three diets supplemented with sodium selenite, methylseleninic acid (MSA) or selenomethionine (SeMet), as well as a Se-deficient and a Se-adequate diet were fed to mice before mammary gland inoculation of 4T1.2 cells. The primary tumor growth, the numbers of cancer cells present in lungs, hearts, livers, kidneys and femurs and several proinflammatory cytokines were measured. We found that inorganic selenite supplementation provided only short-term delay of tumor growth, whereas the two organic SeMet and MSA supplements provided more potent growth inhibition. These diets also affected cancer metastasis differently. Mice fed selenite developed the most extensive metastasis and had an increased incidence of kidney and bone metastasis. On the other hand, mice fed the SeMet diet showed the least amount of cancer growth at metastatic sites. The MSA diet also provided some protection against breast cancer metastasis although the effects were less significant than those of SeMet. The cytokine profiles indicated that serum levels of interlukin-2, interleukin-6, interferon c and vascular endothelial growth factor were elevated in SeMet-supplemented mice. There was no significant difference in tumor growth and the patterns of metastasis between the Se-deficient and Se-adequate groups. Our data suggest that organic Se supplementation may reduce/delay breast cancer metastasis, while selenite may exacerbate it.Breast cancer is the second highest cause of cancer death among women following lung and bronchial cancer. 1 After breast cancer metastasizes to secondary organs, the 5-year survival rate drops dramatically.Because of the strong association between metastasis and poor prognosis, much effort has been focused on early detection. Circulating tumor cells (CTCs) have been used as an early indicator of metastasis. 2 Their presence indicates that metastasis may occur earlier than detectable clinical symptoms. 2 These CTCs or disseminated tumor cells in the bone may remain dormant for years. These findings illustrate the difficulty in determining when metastasis occurs and how to prevent it. One approach may be to use a dietary supplement as a preventive treatment.Selenium (Se) is a micronutrient important to human health, primarily through antioxidant, anti-inflammatory and antiviral mechanisms. 3 Se compounds and selenoproteins are thought to have important anticancer activity and chemopreventive properties. 4,5 Organic Se is present in foods in the forms of selenomethionine (SeMet), selenocysteine (Sec), g-